Table 3.
Univariate | Multivariate | |||
---|---|---|---|---|
| ||||
HR (95%CI) | p-value | HR (95%CI) | p-value | |
OS | ||||
Gleason Grade Group ≥4 | 1.60(0.62–4.12) | 0.33 | ||
iPSA | 1.00 (0.99–1.02) | 0.54 | ||
PSA at Oligometastasis | 1.00 (0.97–1.02) | 0.99 | ||
Number of Metastases | 1.84 (1.26–2.69) | <0.01 | 1.83 (1.26–2.67) | <0.01 |
Visceral metastases | 4.35 (1.25–15.13) | 0.02 | Term removed by model | |
WNT Mutation | 3.861.26–11.83) | 0.02 | 3.87 (1.25–12.00) | 0.02 |
rPFS | ||||
Gleason Grade Group ≥4 | 0.98 (0.72–1.35) | 0.91 | ||
iPSA | 1.00 (1.00–1.01) | 0.22 | ||
PSA at Oligometastasis | 1.0 (1.00–1.01) | 0.60 | ||
Number of Metastases | 1.26 (1.08–1.48) | <0.01 | ||
Visceral metastases | 0.79 (0.37–1.68) | 0.53 | ||
WNT Mutation | 1.01 (0.59–1.73) | 0.97 |
OS: overall survival, rPFS: radiographic progression-free survival